STOCK PURCHASE, AMENDMENT AND ISSUANCE AGREEMENTStock Purchase, Amendment and Issuance Agreement • October 10th, 2014 • Northwest Biotherapeutics Inc • Pharmaceutical preparations
Contract Type FiledOctober 10th, 2014 Company IndustryThis Amendment and Issuance Agreement (the “Agreement”), dated as of October 6, 2014, is by and among Northwest Biotherapeutics, Inc., a Delaware corporation (the “Company”), and the undersigned holder (the “Holder”) of those certain rights to purchase additional shares of Common Stock pursuant to Section 2.2 of the Securities Purchase Agreement (“Purchase Agreement”), dated April 9, 2014, by and among the Company and the Holder (“Overallotment Right”).